A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types

Area of Science:

• Stem Cell Biology
• Genomics
• Developmental Biology

Background:

• Induced pluripotent stem cells (iPSCs) offer significant potential for disease modeling and regenerative medicine.
• Patient-derived iPSCs are increasingly utilized, necessitating robust quality control measures.
• Ensuring iPSC line consistency is crucial for experimental reproducibility across diverse research settings.

Purpose of the Study:

• To establish and present a comprehensive, multistep quality control workflow for newly generated human iPSCs.
• To validate the workflow's effectiveness in assessing critical iPSC benchmarks.
• To ensure the reliability and reproducibility of iPSC lines for downstream applications.

Main Methods:

• Assessment of cell growth dynamics and comparison of different growth media.
• Analysis of genomic integrity using G-band karyotyping and qPCR for common abnormalities.
• Evaluation of pluripotency and trilineage differentiation potential, including specific differentiation into cortical neurons.

Main Results:

• The developed workflow effectively evaluates key quality control parameters for iPSC lines.
• Genomic stability was assessed via karyotyping and qPCR, identifying potential abnormalities.
• Successful trilineage differentiation and specific neuronal differentiation confirmed pluripotency and utility.

Conclusions:

• A standardized quality control workflow is essential for the reliable use of patient-derived iPSCs.
• The presented workflow provides a robust framework for evaluating iPSC lines, promoting research reproducibility.
• This methodology supports the advancement of stem cell research and its clinical applications.